South Africa - The African frontier

Securitisation is booming in South Africa, with issuance reaching record levels in 2006 and further growth expected this year. But there are signs that the local market may be reaching saturation point. Mark Pengelly reports

pg60-hayne-jpg

Securitisation in South Africa has come so far in such a small time that it has left many in the market wondering where it can go next. Until recently, the practice was not widespread: just five years ago, transactions were sparse and regulatory ambiguity clouded the status of special-purpose vehicles (SPVs) set up to facilitate securitisation deals.

Ever since the country's authorities made clear these SPVs would not be regulated as banks under reforms made to the Banks Act in 2001

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact info@risk.net to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Risk.net? View our subscription options

Credit risk & modelling – Special report 2021

This Risk special report provides an insight on the challenges facing banks in measuring and mitigating credit risk in the current environment, and the strategies they are deploying to adapt to a more stringent regulatory approach.

The wild world of credit models

The Covid-19 pandemic has induced a kind of schizophrenia in loan-loss models. When the pandemic hit, banks overprovisioned for credit losses on the assumption that the economy would head south. But when government stimulus packages put wads of cash in…

Most read articles loading...

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here